col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


414 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Emerging Microbes & Infections
  original article Date Title Authors   All Authors
1 [GO] 2024―May―16 The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development Zhen Zhang, Li Zhou, Qianyun Liu, Yucheng Zheng, Xue Tan, Zhixiang Huang, et al. (+18)
2 [GO] 2024―May―09 Epidemic Features and Megagenomic Analysis of Childhood Mycoplasma Pneumoniae post COVID-19 Pandemic: A 6-year Study in Southern China Yi Xu, Chen Yang, Panpan Sun, Fansen Zeng, Qian Wang, Jianlong Wu, et al. (+13)
3 [GO] 2024―Apr―28 Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study Siyue Jia, Zundong Yin, Hongxing Pan, Fuzhen Wang, Xiaoqiang Liu, Qing Wang, et al. (+15)
4 [GO] 2024―Apr―15 Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1 Sijie Yang, Yuanling Yu, Fanchong Jian, Ayijiang Yisimayi, Weiliang Song, Jingyi Liu, et al. (+10)
5 [GO] 2024―Mar―26 Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses Qianchun Gong, Rendi Jiang, Lina Ji, Haofeng Lin, Meiqin Liu, Xiaofang Tang, et al. (+13)
6 [GO] 2024―Mar―22 Coinfection and Nonrandom Recombination Drive the Evolution of Swine Enteric Coronaviruses Jiahui Guo, Yinan Lai, Zhixiang Yang, Wenbo Song, Junwei Zhou, Zhuang Li, et al. (+3)
7 [GO] 2024―Mar―11 Surveillance of SARS-CoV-2 in wastewater by quantitative PCR and digital PCR: a case study in Shijiazhuang city, Hebei province, China Xiaoru Chai, Shiyou Liu, Chao Liu, Jiaxuan Bai, Juntao Meng, Hong Tian, et al. (+4)
8 [GO] 2024―Feb―29 The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial Chunhua Zhou, Yuanzheng Qiu, Jianxin Wang, Xiang Zhong, Xiufang Zhu, Xiaojing Huang, et al. (+11)
9 [GO] 2024―Feb―20 Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies Jing Lu, Shudan Tan, Hao Gu, Kunpeng Liu, Wei Huang, Zhaoli Yu, et al. (+15)
10 [GO] 2024―Jan―24 Receptor-binding domain-associated serotypes of SARS-CoV-2 Zezhong Liu, Lu Lu, Shibo Jiang
11 [GO] 2024―Jan―19 Neutralizing and Enhancing Monoclonal Antibodies in SARS-CoV-2 Convalescent Patients: Lessons from Early Variant Infection and Impact on Shaping Emerging Variants Frédéric Coutant, Franck Touret, Jean-Jacques Pin, Marina Alonzo, Cécile Baronti, Sandie Munier, et al. (+4)
12 [GO] 2024―Jan―02 In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates Ami Patel, Kyle Rosenke, Elizabeth M. Parzych, Friederike Feldmann, Suman Bharti, Amanda J. Griffin, et al. (+23)
13 [GO] 2023―Dec―19 The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity Alba Escalera, Manon Laporte, Sam Turner, Umut Karakus, Ana S. Gonzalez-Reiche, Adriana van de Guchte, et al. (+6)
14 [GO] 2023―Dec―11 An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV Hailong Guo, Bomsoo Cho, Paul R. Hinton, Sijia He, Yongjun Yu, Ashwin Kumar Ramesh, et al. (+22)
15 [GO] 2023―Dec―06 Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines Teresa Aydillo, Maria Balsera, Amaya Rojo-Fernandez, Alba Escalera, Celia Salamanca-Rivera, Jerónimo Pachón, et al. (+5)
16 [GO] 2023―Dec―04 Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents Qihong Yan, Yudi Zhang, Ruitian Hou, Wenjing Pan, Huan Liang, Xijie Gao, et al. (+17)
17 [GO] 2023―Nov―22 The Characterization of CD8+ T-cell Responses in COVID-19 Yuanting Yang, Heather Miller, Maria G Byazrova, Fabio Cndotti, Kamel Benlagha, Niels Olsen Saraiva Camara, et al. (+7)
18 [GO] 2023―Nov―20 Monovalent XBB.1.5 booster vaccination induces broad-spectrum of SARS-CoV-2 neutralizing antibodies Nan Huo, Shipo Wu, Yudong Wang, Busen Wang, Zhe Zhang, Jinlong Zhang, et al. (+3)
19 [GO] 2023―Nov―16 Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China Ying Liu, Jiayou Zhang, Wen Liu, Yongbing Pan, Shunan Ruan, Xuanxuan Nian, et al. (+17)
20 [GO] 2023―Nov―08 Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern Konner Cool, Natasha N. Gaudreault, Jessie D. Trujillo, Igor Morozov, Chester D. McDowell, Dashzeveg Bold, et al. (+16)
21 [GO] 2023―Nov―07 Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial Jia-Wei Xu, Bu-Sen Wang, Ping Gao, Hai-Tao Huang, Fei-Yu Wang, Wei Qiu, et al. (+9)
22 [GO] 2023―Oct―26 Low level of tonic interferon signaling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids Meaghan Flagg, Kerry Goldin, Lizzette Pérez-Pérez, Manmeet Singh, Brandi N. Williamson, Nathanael Pruett, et al. (+2)
23 [GO] 2023―Oct―23 Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination Rahul K. Suryawanshi, Taha Y. Taha, Maria McCavitt-Malvido, Ines Silva, Mir M. Khalid, Abdullah M. Syed, et al. (+27)
24 [GO] 2023―Oct―12 Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1 Yanping Hu, Jing Zou, Chaitanya Kurhade, Xiangxue Deng, Hope C. Chang, Debora K. Kim, et al. (+3)
25 [GO] 2023―Oct―11 Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3 Julia N. Faraone, Panke Qu, Negin Goodarzi, Yi-Min Zheng, Claire Carlin, Linda J. Saif, et al. (+5)
26 [GO] 2023―Sep―21 A follow-up study on the recovery and reinfection of Omicron COVID-19 patients in Shanghai, China Mengna Lin, Kangli Cao, Feixiang Xu, Xueling Wu, Yao Shen, Su Lu, et al. (+16)
27 [GO] 2023―Sep―20 Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector Ziteng Liang, Xi Wu, Jiajing Wu, Shuo Liu, Jincheng Tong, Tao Li, et al. (+8)
28 [GO] 2023―Sep―12 Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in a resource-limited setting Andres Moreira-Soto, Alfredo Bruno, Doménica de Mora, Michelle Paez, Jimmy Garces, Ben Wulf, et al. (+8)
29 [GO] 2023―Sep―06 Betacoronaviruses SARS-CoV-2 and HCoV-OC43 Infections in IGROV-1 Cell Line Require Aryl Hydrocarbon Receptor Meisam Yousefi, Wai Suet Lee, Wharton OY Chan, Wei He, Marcus G Mah, Cythia Lingli Yong, et al. (+18)
30 [GO] 2023―Aug―22 Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty Xiangqi Li, Chaobao Zhang, Zhijun Bao
31 [GO] 2023―Aug―10 Neighborhood Watch: Genomic epidemiology of SARS-CoV-2 variants circulating in a German federal state, Mecklenburg-Western Pomerania, in 2020-2022 Christian Kohler, Jacqueline King, Lina Stacker, Katja V. Goller, Juliane Moritz, Anne Pohlmann, et al. (+12)
32 [GO] 2023―Aug―09 A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants Jimena Pérez-Vargas, Liam J. Worrall, Andrea D. Olmstead, Anh-Tien Ton, Jaeyong Lee, Ivan Villanueva, et al. (+24)
33 [GO] 2023―Aug―05 SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters Biao Zhou, Runhong Zhou, Jasper Fuk-Woo Chan, Jianwei Zeng, Qi Zhang, Shuofeng Yuan, et al. (+33)
34 [GO] 2023―Aug―03 An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen Xinling Wang, Lujia Sun, Zezhong Liu, Lixiao Xing, Yun Zhu, Wei Xu, et al. (+3)
35 [GO] 2023―Jul―27 Host genetic polymorphisms involved in long-term symptoms of COVID-19 Wanvisa Udomsinprasert, Nuttakant Nontawong, Wacharapol Saengsiwaritt, Bhakbhoom Panthan, Poramate Jiaranai, Nartthawee Thongchompoo, et al. (+6)
36 [GO] 2023―Jul―24 A comparative study on persistence and viability of SARS-CoV-2 wild-type and omicron variant on artificially contaminated surfaces: the role of fomites Giovanna Fusco, Gerardo Picazio, Lorena Cardillo, Alessia Pucciarelli, Luisa Marati, Federica Di Maggio, et al. (+5)
37 [GO] 2023―Jul―21 Preparation for the Next Pandemic: Challenges in Strengthening Global Health Systems and Surveillance Kelvin Hei-Yeung Chiu, Siddharth Sridhar, Kwok-Yung Yuen
38 [GO] 2023―Jul―06 Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19 Maria E. Hasing, Bonita E. Lee, Tiejun Gao, Qiaozhi Li, Yuanyuan Qiu, Erik Ellehoj, et al. (+15)
39 [GO] 2023―Jun―24 Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea Sangyi Lee, Dong-Wook Lee, Jeong-Min Kim, Da-Won Kim, Ji-Yun Kim, Jeong-Ah Kim, et al. (+6)
40 [GO] 2023―Jun―19 Assessment and sero-diagnosis for coronaviruses with risk of human spillover Xiao-Shuang Zheng, Qi Wang, Ting-ting Xie, Hao-rui Si, Wei Zhang, Yan Zhu, et al. (+4)
41 [GO] 2023―Jun―14 Sera from Breakthrough Infections with SARS-CoV-2 BA.5 or BF.7 Showed Lower Neutralization Activity against XBB.1.5 and CH.1.1 Shuo Liu, Ziteng Liang, Jianhui Nie, Wei bo Gao, Xinyi Li, Li Zhang, et al. (+3)
42 [GO] 2023―Jun―12 Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman Ihab El Masry, Salim Al Makhladi, Mohsin Al Abdwany, Afrah Al Subhi, Hatim Eltahir, Samuel Cheng, et al. (+7)
43 [GO] 2023―Jun―08 Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022 Anna Solastie, Tuomo Nieminen, Nina Ekström, Hanna Nohynek, Lasse Lehtonen, Arto A. Palmu, Merit Melin
44 [GO] 2023―Jun―06 SARS-CoV-2 detection and inactivation in water and wastewater: Review on analytical methods, limitations and future research recommendations Parashuram Kallem, Hanaa Hegab, Habiba Alsafar, Shadi W. Hasan, Fawzi Banat
45 [GO] 2023―Jun―05 A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China Jianpeng Cai, Ke Lin, Haocheng Zhang, Quanlin Xue, Kun Zhu, Guanmin Yuan, et al. (+5)
46 [GO] 2023―Jun―05 An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults Tao Li, Deyan Luo, Nianzhi Ning, Xin Wang, Liangyan Zhang, Shuangli Zhu, et al. (+8)
47 [GO] 2023―May―31 SARS-CoV-2 spike S2-specific neutralizing antibodies Chia-Jung Li, Shih-Chung Chang
48 [GO] 2023―May―23 The Ecology of Viruses in Urban Rodents with a Focus on SARS-CoV-2 Adam M. Fisher, George Airey, Yuchen Liu, Matthew Gemmell, Jordan Thomas, Eleanor G. Bentley, et al. (+5)
49 [GO] 2023―May―16 Cell-intrinsic genomic reassortment of pandemic H1N1 2009 and Eurasian avian-like swine influenza viruses results in potentially zoonotic variants Verónica A. Ferrando, Marcel E. Friedrich, Shrey Gandhi, Alexander Mellmann, Dörthe Masemann, Anmari Christersson, et al. (+7)
50 [GO] 2023―May―10 Reciprocal enhancement of SARS-CoV-2 and influenza virus replication in human pluripotent stem cell-derived lung organoids Min Jung Kim, Sumi Kim, Heeyeon Kim, Dayeon Gil, Hyeong-Jun Han, Rajesh K. Thimmulappa, et al. (+2)
51 [GO] 2023―May―09 Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) Nasal Spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study Rui Song, Gang Zeng, Jianxing Yu, Xing Meng, Xiaoyou Chen, Jing Li, et al. (+6)
52 [GO] 2023―May―05 Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation Zhu-Chun Beia, Huanhuan Yu, Hong Wang, Qingyun Li, Baogang Wang, Dongna Zhang, et al. (+4)
53 [GO] 2023―May―03 Waning effectiveness against COVID-19-related hospitalisation, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, et al. (+8)
54 [GO] 2023―May―03 Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2 Qian Wang, Andre Yanchen Yeh, Yicheng Guo, Hiroshi Mohri, Jian Yu, David D. Ho, Lihong Liu
55 [GO] 2023―Apr―28 Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism Cody J. Bills, Hongjie Xia, John Yun-Chung Chen, Jason Yeung, Birte Kalveram, David Walker, et al. (+2)
56 [GO] 2023―Apr―27 The Unreversible Reduced but Persistent Activated NK and CD8+ T cell in Severe/Critical COVID-19 during Omicron Pandemic in China Ling Qin, Xinmin Duan, Jay Zengjun Dong, Yue Chang, Yang Han, Yan Li, et al. (+6)
57 [GO] 2023―Apr―27 MERS-CoV Seroconversion amongst Malaysian Hajj Pilgrims Returning from the Middle East, 2016-2018: Results from the MERCURIAL Multiyear Prospective Cohort Study Jefree Johari, Robert D. Hontz, Brian L. Pike, Tupur Husain, Norhayati Rusli, Rozainanee Mohd-Zain, et al. (+12)
58 [GO] 2023―Apr―26 Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly-weaned hamsters Can Li, Wenchen Song, Jasper Fuk-Woo Chan, Yanxia Chen, Feifei Liu, Zhanhong Ye, et al. (+10)
59 [GO] 2023―Apr―18 Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review Lindsay A. Gaudet, Jennifer Pillay, Sabrina Saba, Dianne Zakaria, Nicholas Cheta, Hélène Gardiner, et al. (+5)
60 [GO] 2023―Apr―15 Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice Qing Huang, Ran An, Haixuan Wang, Yun Yang, Cong Tang, Junbin Wang, et al. (+8)
61 [GO] 2023―Apr―15 A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases Subodh Kumar Samrat, Qamar Bashir, Ran Zhang, Yiding Huang, Yuchen Liu, Xiangmeng Wu, et al. (+7)
62 [GO] 2023―Apr―11 Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages Li Guo, Qiao Zhang, Jingchuan Zhong, Lan Chen, Wentao Jiang, Tingxuan Huang, et al. (+16)
63 [GO] 2023―Apr―11 Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain) Laura Ciuffreda, José M. Lorenzo-Salazar, Diego García-Martínez de Artola, Helena Gil-Campesino, Julia Alcoba-Florez, Héctor Rodríguez-Pérez, et al. (+8)
64 [GO] 2023―Apr―11 Potent Immunogenicity and Broad-Spectrum Protection Potential of Microneedle Array Patch-Based COVID-19 DNA Vaccine Candidates Encoding Dimeric RBD Chimera of SARS-CoV and SARS-CoV-2 Variants Feng Fan, Xin Zhang, Zhiyu Zhang, Yuan Ding, Limei Wang, Xin Xu, et al. (+11)
65 [GO] 2023―Mar―29 Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing Renyang Tong, Lingjie Luo, Yichao Zhao, Mingze Sun, Ronghong Li, Jianmei Zhong, et al. (+19)
66 [GO] 2023―Mar―23 Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade Alexandra PM Cloherty, Anusca G Rader, Kharishma S Patel, Jimena Perez-Vargas, Connor AH Thompson, Siobhan Ennis, et al. (+6)
67 [GO] 2023―Mar―22 The role of dendritic cells in COVID-19 infection Xuying Wang, Fei Guan, Heather Miller, Maria G Byazrova, Fabio Cndotti, Kamel Benlagha, et al. (+4)
68 [GO] 2023―Mar―16 Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines Zezhong Liu, Lu Lu, Shibo Jiang
69 [GO] 2023―Mar―15 Impact of National Omicron Outbreak at the End of 2022 to the Future Outlook of COVID-19 in China Liwei Zheng, Shuying Liu, Fengmin Lu
70 [GO] 2023―Mar―05 Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Carlos King Ho Wong, Xue Li, et al. (+6)
71 [GO] 2023―Feb―28 HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19 Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, et al. (+8)
72 [GO] 2023―Feb―07 SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors Shuai Xia, Lijue Wang, Fanke Jiao, Xueying Yu, Wei Xu, Ziqi Huang, et al. (+6)
73 [GO] 2023―Feb―01 Coronavirus RNA-dependent RNA polymerase interacts with the p50 regulatory subunit of host DNA polymerase delta and plays a synergistic role with RNA helicase in the induction of DNA damage response and cell cycle arrest in S phase Li Quan, Xinxin Sun, Linghui Xu, Rui Ai Chen, Ding Xiang Liu
74 [GO] 2023―Jan―30 Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: How many booster doses do we need? Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, et al. (+10)
75 [GO] 2023―Jan―19 SARS-CoV-2 infection-induced immunity reduces rates of reinfection and hospitalization caused by the Delta or Omicron variants Marc-Antoine de La Vega, Efstathia Polychronopoulou,   Ara, Zhe Ding, Qixing Liu, Jiaming Lan, et al. (+6)
76 [GO] 2023―Jan―09 Genetic diversity and molecular epidemiology of Middle East Respiratory Syndrome Coronavirus in dromedaries in Ethiopia, 2017 to 2020. Ziqi Zhou, Abraham Ali, Elias Walelign, Getnet F. Demissié, Ihab El Masry, Takele Abayneh, et al. (+13)
77 [GO] 2023―Jan―06 The nasopharyngeal microbiome in COVID-19 Sergio Candel, Sylwia D. Tyrkalska, Carmen Álvarez-Santacruz, Victoriano Mulero
78 [GO] 2023―Jan―03 Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages Hongjie Xia, Jason Yeung, Birte Kalveram, Cody J. Bills, John Yun-Chung Chen, Chaitanya Kurhade, et al. (+9)
79 [GO] 2023―Jan―02 Host Antiviral Factors Hijack Furin to Block SARS-CoV-2, Ebola Virus, and HIV-1 Glycoproteins Cleavage Changqing Yu, Guosheng Wang, Qiang Liu, Jingbo Zhai, Mengzhou Xue, Qiang Li, et al. (+2)
80 [GO] 2022―Dec―30 The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development Haiyun Yu, Fei Guan, Heather Miller, Jiahui Lei, Chaohong Liu
81 [GO] 2022―Dec―29 Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study Jeong-Hwan Hwang, Yeon Seok You, Sang Woo Yeom, Min Gyu Lee, Jong-hwan Lee, Min Gul Kim, Jong Seung Kim
82 [GO] 2022―Dec―09 Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C-C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections Kelvin Hei-Yeung Chiu, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Kit-Hang Leung, Xin Li, Ivan Fan-Ngai Hung, et al. (+3)
83 [GO] 2022―Dec―05 Changes in the Characteristics and Outcomes of COVID-19 Patients from the Early Pandemic to the Delta Variant Epidemic: A Nationwide Population-based Study Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, et al. (+7)
84 [GO] 2022―Dec―02 A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance K.L. Brown, A. Ceci, C. Roby, R. Briggs, D. Ziolo, R. Korba, et al. (+5)
85 [GO] 2022―Dec―01 Induction of Significant Neutralizing Antibodies against SARS-CoV-2 by a Highly Attenuated Pangolin Coronavirus Variant with a 104nt Deletion at the 3'-UTR Shanshan Lu, Shengdong Luo, Chang Liu, Muli Li, Xiaoping An, Mengzhe Li, et al. (+5)
86 [GO] 2022―Nov―29 Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination Miao Wang, Bing Zhou, Qing Fan, Xinrong Zhou, Xuejiao Liao, Jingyan Lin, et al. (+6)
87 [GO] 2022―Nov―25 Mouse Study of Combined DNA/Protein COVID-19 Vaccine to Boost High Levels of Antibody and Cell Mediated Immune Responses Qian He, Shuying Liu, Zhenglun Liang, Shan Lu, Wei Cun, Qunyan Mao
88 [GO] 2022―Nov―18 Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: Real-world study in Jilin Province, China Hongqin Xu, Hongyan Li, Hailong You, Peng Zhang, Nan Li, Nan Jiang, et al. (+32)
89 [GO] 2022―Nov―17 A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern I. Jung Lee, Yu-Hua Lan, Ping-Yi Wu, Yan-Wei Wu, Yu-Hung Chen, Sheng-Che Tseng, et al. (+16)
90 [GO] 2022―Nov―14 Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by Serum live neutralization test based on a prospective cohort Liguo Zhu, Naiying Mao, Changhua Yi, Aidibai Simayi, Jialu Feng, Yi Feng, et al. (+17)
91 [GO] 2022―Nov―11 Bordetella hinzii bacteremia in a patient with SARS-CoV-2 infection Kamilia Chahi, Christine Collienne, Ahalieyah Anantharajah, Hector Rodriguez-Villalobos, Philippe Hantson
92 [GO] 2022―Nov―10 Structural insights into broadly neutralizing antibodies against SARS-CoV-2 elicited by hybrid immunity Mengxiao Luo, Biao Zhou, Eswar R. Reddem, Bingjie Tang, Bohao Chen, Runhong Zhou, et al. (+11)
93 [GO] 2022―Oct―27 Risk factors and preventive interventions for post Covid-19 condition: systematic review Jennifer Pillay, Sholeh Rahman, Samantha Guitard, Aireen Wingert, Lisa Hartling
94 [GO] 2022―Oct―26 A Novel RBD-Protein/Peptide Vaccine Elicits Broadly Neutralizing Antibodies and Protects Mice and Macaques against SARS-CoV-2 Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, Wen-Jiun Peng, Juin-Hua Huang, Be-Shen Kuo, et al. (+29)
95 [GO] 2022―Oct―26 Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants Qihong Yan, Ruitian Hou, Xiaohan Huang, Yanjun Zhang, Ping He, Yudi Zhang, et al. (+9)
96 [GO] 2022―Oct―14 Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques Pingchao Li, Qian Wang, Yizi He, Chenchen Yang, Zhengyuan Zhang, Zijian Liu, et al. (+12)
97 [GO] 2022―Oct―10 Healthy Outcomes of Patients with COVID-19 Two Years after the Infection: A Prospective Cohort Study Dapeng Li, Xuejiao Liao, Zhi Liu, Zhenghua Ma, Jingke Dong, Guoqin Zheng, et al. (+6)
98 [GO] 2022―Oct―07 Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022 Xinhua Chen, Xuemei Yan, Kaiyuan Sun, Nan Zheng, Ruijia Sun, Jiaxin Zhou, et al. (+6)
99 [GO] 2022―Oct―05 Heterologous booster with inhaled Adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants Jiaying Zhong, Shuo Liu, Tingting Cui, Jingxin Li, Fengcai Zhu, Nanshan Zhong, et al. (+3)
100 [GO] 2022―Sep―25 Pathogen-Host Adhesion between SARS-CoV-2 Spike Proteins from Different Variants and Human ACE2 Studied at Single-Molecule and Single-Cell Levels Xiaoxu Zhang, Bixia Hong, Peng Wei, Pengfei Pei, Haifeng Xu, Long Chen, et al. (+5)
101 [GO] 2022―Sep―25 MERS-CoV nsp1 regulates autophagic flux via mTOR signaling and dysfunctional lysosomes Yujie Feng, Zhaoyi Pan, Zhihui Wang, Zhengyang Lei, Songge Yang, Huajun Zhao, et al. (+4)
102 [GO] 2022―Sep―15 The Modulatory Action of C-Vx Substance on the Immune System in COVID-19 Ilhan Tahrali, Nilgun Akdeniz, Vuslat Yilmaz, Umut C. Kucuksezer, Fatma B. Oktelik, Ozkan Ozdemir, et al. (+7)
103 [GO] 2022―Sep―15 Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies Qingrui Huang, Xiaonan Han, Jinghua Yan
104 [GO] 2022―Sep―14 Consideration of COVID-19 beyond the human-centred approach of prevention and control: the ONE-HEALTH perspective Qin Li, Robert Bergquist, Liz Grant, Jun-Xia Song, Xin-Yu Feng, Xiao-Nong Zhou
105 [GO] 2022―Sep―13 Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections Carla Saade, Karen Brengel-Pesce, Alexandre Gaymard, Mary-Anne Trabaud, Gregory Destras, Guy Oriol, et al. (+18)
106 [GO] 2022―Sep―07 A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine Akihiko Sakamoto, Hiroaki Osawa, Hinata Hashimoto, Tetsushi Mizuno, Ammar A. Hasyim, Yu-ichi Abe, et al. (+5)
107 [GO] 2022―Sep―07 COVID-19: imbalanced cell-mediated immune response drives to immunopathology Jun Wang, Qian Li, YuanWang Qiu, Hongzhou Lu
108 [GO] 2022―Sep―07 Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Variants of Concern in Real-world: a Literature Review and Meta-analysis Weihao Shao, Xiaorui Chen, Caifang Zheng, Haoshuang Liu, Gaili Wang, Bowen Zhang, et al. (+2)
109 [GO] 2022―Sep―06 Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU Farnaz Daneshnia, João N. de Almeida Júnior, Amir Arastehfar, Lisa Lombardi, Erika Shor, Lis Moreno, et al. (+6)
110 [GO] 2022―Aug―30 Spike mutations contributing to the altered entry preference of SARS-CoV-2 Omicron BA.1 and BA.2 Bingjie Hu, Jasper Fuk-Woo Chan, Huan Liu, Yuanchen Liu, Yue Chai, Jialu Shi, et al. (+14)
111 [GO] 2022―Aug―27 Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates Amir I. Tukhvatulin, Ilya V. Gordeychuk, Inna V. Dolzhikova, Alina S. Dzharullaeva, Marina E. Krasina, Ekaterina O. Bayurova, et al. (+24)
112 [GO] 2022―Aug―25 Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Ji-Min Seo, Bobin Kang, Rina Song, Hanmi Noh, Cheolmin Kim, Jong-In Kim, et al. (+18)
113 [GO] 2022―Aug―24 Association of COVID-19 vaccination before conception with maternal liver function during early pregnancy: a cohort study of 7745 Chinese pregnant women Yan Zhao, Yongbo Zhao, Mengyuan Li, Yicheng Zhou, Yijun Zhang, Xin Su, et al. (+2)
114 [GO] 2022―Aug―24 3D ex vivo tissue platforms to investigate the early phases of influenza A virus- and SARS-CoV-2-induced respiratory diseases Sebastian Schloer, Daniel Treuherz, Aileen Faist, Marlous de Witt, Katharina Wunderlich, Rainer Wiewrodt, et al. (+8)
115 [GO] 2022―Aug―23 Outbreak of cutaneous leishmaniasis before and during the COVID-19 pandemic in Jahrom, an endemic region in southwest of Iran Samaneh Mazaherifar, Kavous Solhjoo, Amir Abdoli
116 [GO] 2022―Aug―23 Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study Rujipas Sirijatuphat, Weerawat Manosuthi, Suvimol Niyomnaitham, Andrew Owen, Katherine Kradangna Copeland, Lantharita Charoenpong, et al. (+4)
117 [GO] 2022―Aug―18 Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, Anna Hoi Ying Mok, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, et al. (+14)
118 [GO] 2022―Aug―17 Furin cleavage is required for swine acute diarrhea syndrome coronavirus spike protein-mediated cell-cell fusion Jinman Kim, Jaewon Yoon, Jung-Eun Park
119 [GO] 2022―Aug―11 Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally-infected, captive white-tailed deer (Odocoileus virginianus), Texas Sarah A. Hamer, Chase Nunez, Christopher M. Roundy, Wendy Tang, Logan Thomas, Jack Richison, et al. (+6)
120 [GO] 2022―Aug―09 The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage Ronghui Liang, Zi-Wei Ye, Chon Phin Ong, Zhenzhi Qin, Yubin Xie, Yilan Fan, et al. (+17)
121 [GO] 2022―Aug―04 Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave Guanzhu Lu, Yi Zhang, Haocheng Zhang, Jingwen Ai, Liu He, Xiaoling Yuan, et al. (+7)
122 [GO] 2022―Aug―02 Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein Aiping Wang, Yuanyuan Tian, Hongliang Liu, Peiyang Ding, Yumei Chen, Chao Liang, et al. (+5)
123 [GO] 2022―Jul―28 Comparative global B cell receptor repertoire difference induced by SARS-CoV-2 infection or vaccination via single-cell V(D)J sequencing Bing He, Shuning Liu, Mengxin Xu, Yunqi Hu, Kexin Lv, Yuanyuan Wang, et al. (+20)
124 [GO] 2022―Jul―26 SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Wan-Mui Chan, Carol Ho-Yan Fong, Xiaojuan Zhang, Lu Lu, et al. (+7)
125 [GO] 2022―Jul―19 A Case-Case Study on the Effect of Primary and Booster immunization with China-produced COVID-19 Vaccines on Prevention of Pneumonia and Viral Load among Vaccinated Persons infected by Delta and Omicron Variants Dan Wu, Ying Ye, Lin Tang, Ai-Bin Wang, Rui Zhang, Zhao-Hui Qian, et al. (+17)
126 [GO] 2022―Jul―07 Effect of Oral Antiseptics in Reducing SARS-CoV-2 Infectivity: Evidence from a Randomized Double-blind Clinical Trial Álvaro Sánchez Barrueco, María Victoria Mateos-Moreno, Yolanda Martínez-Beneyto, Elisa García-Vázquez, Alfonso Campos González, Javier Zapardiel Ferrero, et al. (+11)
127 [GO] 2022―Jul―06 Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by 3 doses of BNT162b2 vaccine or BA.1 infection Chaitanya Kurhade, Jing Zou, Hongjie Xia, Mingru Liu, Qi Yang, Mark Cutler, et al. (+8)
128 [GO] 2022―Jul―06 Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens Hu-Dachuan Jiang, Xi-ling Guo, Peng-Fei Jin, Rong Tang, Jing-Xin Li, Feng-Cai Zhu
129 [GO] 2022―Jul―05 Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters Melanie Rissmann, Danny Noack, Debby van Riel, Katharina S. Schmitz, Rory D. de Vries, Peter van Run, et al. (+7)
130 [GO] 2022―Jul―04 SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern (VOCs) including Omicron Yuanmei Zhu, Xiaojing Dong, Nian Liu, Tong Wu, Huihui Chong, Xiaobo Lei, et al. (+3)
131 [GO] 2022―Jul―01 Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice Xingxing Li, Ling Wang, Jingjing Liu, Enyue Fang, Xiaohui Liu, Qinhua Peng, et al. (+18)
132 [GO] 2022―Jun―27 An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry Xi Lin, Liyan Guo, Sheng Lin, Zimin Chen, Fanli Yang, Jing Yang, et al. (+14)
133 [GO] 2022―Jun―22 Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: Comparison to influenza and parainfluenza infections Winnie W.Y. Tso, Mike Y.W. Kwan, Yu Liang Wang, Lok Kan Leung, Daniel Leung, Gilbert T. Chua, et al. (+8)
134 [GO] 2022―Jun―21 Lessons Learned from the COVID-19 Control Strategy of the XXXII Tokyo Summer Olympics and the XXIV Beijing Winter Olympics Yi Zhang, Jingwen Ai, Jing Bao, Wenhong Zhang
135 [GO] 2022―Jun―21 Modulation of Viral Replication, Apoptosis and Antiviral Response by Induction and Mutual Regulation of EGR and AP-1 Family Genes During Coronavirus Infection Lixia Yuan, To Sing Fung, Jiawen He, Rui Ai Chen, Ding Xiang Liu
136 [GO] 2022―Jun―16 Absence of SARS-CoV-2 in a captive white-tailed deer population in Alabama, USA Subarna Barua, Chad H. Newbolt, Stephen S. Ditchkoff, Calvin Johnson, Sarah Zohdy, Rachel Smith, Chengming Wang
137 [GO] 2022―Jun―10 Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial Xuan-Yi Wang, Syed Faisal Mahmood, Fang Jin, Wee Kooi Cheah, Muhammad Ahmad, Mian Amjad Sohail, et al. (+14)
138 [GO] 2022―May―26 Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection Huang Liang, Peiyan Zheng, Qian Wang, Yijun Deng, Dan Liang, Haisu Yi, et al. (+13)
139 [GO] 2022―May―24 The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants Yuxin Chen, Lin Chen, Shengxia Yin, Yue Tao, Liguo Zhu, Xin Tong, et al. (+12)
140 [GO] 2022―May―23 mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern Haomeng Wang, Zhao Chen, Zhenghua Wang, Jin Li, Zhihong Yan, Jinbo Yuan, et al. (+20)
141 [GO] 2022―May―23 Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS María C. García-Hidalgo, Jessica González, Iván D. Benítez, Paola Carmona, Sally Santisteve, Manel Pérez-Pons, et al. (+21)
142 [GO] 2022―May―19 ACE2 Decoy Receptor Generated by High-throughput Saturation Mutagenesis Efficiently Neutralizes SARS-CoV-2 and Its Prevalent Variants Bolun Wang, Junxuan Zhao, Shuo Liu, Jingyuan Feng, Yufeng Luo, Xinyu He, et al. (+8)
143 [GO] 2022―May―17 An Open, Prospective Cohort Study of VV116 in Chinese Participants Infected with SARS-CoV-2 Omicron Variants Yinzhong Shen, Jingwen Ai, Na Lin, Haocheng Zhang, Yang Li, Hongyu Wang, et al. (+17)
144 [GO] 2022―May―10 Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022 Zhanwei Du, Linwei Tian, Dong-Yan Jin
145 [GO] 2022―May―02 Real-World Effectiveness of Homologous and Heterologous BNT162b2, CoronaVac, and AZD1222 Booster Vaccination Against Delta and Omicron SARS-CoV-2 Infection Jing Lian Suah, Boon Hwa Tng, Peter Seah Keng Tok, Masliyana Husin, Thevesh Thevananthan, Kalaiarasu M. Peariasamy, Sheamini Sivasampu
146 [GO] 2022―Apr―27 Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2 Na Chen, Baoge Zhang, Lulu Deng, Bing Liang, Jihui Ping
147 [GO] 2022―Apr―25 Impact of prior vaccination on clinical outcomes of patients with COVID-19 Woo Jung Seo, Jiyeon Kang, Hyung Koo Kang, So Hee Park, Hyeon-Kyoung Koo, Hye Kyeong Park, et al. (+4)
148 [GO] 2022―Apr―14 N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro Michaela Lackner, Annika Rössler, André Volland, Marlena Nastassja Stadtmüller, Brigitte Müllauer, Zoltan Banki, et al. (+11)
149 [GO] 2022―Apr―12 COVID-19 Breakthrough Infections and Humoral Immune Response among BNT162b2 Vaccinated Healthcare Workers in Malaysia Su Lan Yang, Adiratna Mat Ripen, Chin Tho Leong, Jen Ven Lee, Chia How Yen, Avinash Kumar Chand, et al. (+13)
150 [GO] 2022―Apr―05 Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China Jun Cai, Juan Yang, Xiaowei Deng, Cheng Peng, Xinhua Chen, Qianhui Wu, et al. (+7)
151 [GO] 2022―Apr―05 The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2 Xiaolong Tian, Xiaoyi Zhu, Wenping Song, Zhenlin Yang, Yanling Wu, Tianlei Ying
152 [GO] 2022―Apr―04 Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV Ling Ao, Ting Lu, Yu Cao, Zhiwei Chen, Yuting Wang, Zisheng Li, et al. (+11)
153 [GO] 2022―Mar―29 Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022 Pak-Hin Hinson Cheung, Chi-Ping Chan, Dong-Yan Jin
154 [GO] 2022―Mar―28 SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, et al. (+14)
155 [GO] 2022―Mar―28 Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: A systematic review and meta-analysis Su-Yeon Yu, Dae-Hyup Koh, Miyoung Choi, Seungeun Ryoo, Kyungmin Huh, Joon Sup Yeom, Young Kyung Yoon
156 [GO] 2022―Mar―28 Transcriptomic analysis of the innate immune signatures of SARS-CoV-2 protein subunit vaccine ZF2001 and a mRNA vaccine RRV Qian Wang, Ziyang Song, Jinghuan Yang, Qian He, Qunying Mao, Yu Bai, et al. (+8)
157 [GO] 2022―Mar―28 SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in Arf6-dependent manner Yun-Qi Zhou, Ke Wang, Xue-Yan Wang, Hong-Yong Cui, Yongxiang Zhao, Ping Zhu, Zhi-Nan Chen
158 [GO] 2022―Mar―25 Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters C. J. Field, T.A. Heinly, D. R. Patel, D. G. Sim, E. Luley, S. L. Gupta, et al. (+3)
159 [GO] 2022―Mar―23 Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2 Sven-Kevin Hotop, Susanne Reimering, Aditya Shekhar, Ehsaneddin Asgari, Ulrike Beutling, Christine Dahlke, et al. (+10)
160 [GO] 2022―Mar―23 Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells Jiapei Yu, Hui Li, Ju Jia, Zhisheng Huang, Shuai Liu, Ying Zheng, et al. (+10)
161 [GO] 2022―Mar―21 A tandem-repeat dimeric RBD protein-based COVID-19 vaccine ZF2001 protects mice and nonhuman primates Yaling An, Shihua Li, Xiyue Jin, Jian-bao Han, Kun Xu, Senyu Xu, et al. (+22)
162 [GO] 2022―Mar―21 Identification of a Recombinant Equine Coronavirus in Donkey, China Peng-Fei Qi, Xing-Yi Gao, Jing-Kai Ji, Yan Zhang, Shao-Hua Yang, Kai-Hui Cheng, et al. (+9)
163 [GO] 2022―Mar―16 RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant Jianing Yang, Xuejiao Hu, Wenzhuo Wang, Yujing Yang, Xinqiang Zhang, Wei Fang, et al. (+3)
164 [GO] 2022―Mar―16 Analysis of SARS-CoV-2 Variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity Li Zhang, Qianqian Li, Jiajing Wu, Yuanling Yu, Yue Zhang, Jianhui Nie, et al. (+16)
165 [GO] 2022―Mar―11 A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants Joy-Yan Lam, Yau-Yee Ng, Chun-Kit Yuen, Wan-Man Wong, Kwok-Yung Yuen, Kin-Hang Kok
166 [GO] 2022―Mar―10 SARS-CoV-2 reinfection and COVID-19 severity Nhu Ngoc Nguyen, Linda Houhamdi, Van Thuan Hoang, Jeremy Delerce, Léa Delorme, Philippe Colson, et al. (+4)
167 [GO] 2022―Mar―08 Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2 including Delta and Omicron variants Hanjun Zhao, Xinjie Meng, Zheng Peng, Hoiyan Lam, Chuyuan Zhang, Xinxin Zhou, et al. (+4)
168 [GO] 2022―Mar―04 A 1-year longitudinal study on COVID-19 convalescents reveals persistence of anti-SARS-CoV-2 humoral and cellular immunity Li Yang, Xi Wang, Xu-Rui Shen, Rong Geng, Nan Xie, Jun-Feng Han, et al. (+3)
169 [GO] 2022―Mar―01 COVID-19 mass vaccination - an illustration of the impact of syringe choice on the effectiveness of mass vaccination campaigns Mazet Roseline, Choisnard Luc, Leenhardt Julien, Epaulard Olivier, Brudieu Etienne, Bedouch Pierrick
170 [GO] 2022―Mar―01 Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coronavirus 2 variants Zhuxiang Zhao, Tingting Cui, Mingzhu Huang, Shuo Liu, Xiaoling Su, Guichang Li, et al. (+7)
171 [GO] 2022―Feb―25 Viro-immunological evaluation in an immunocompromised patient with long-lasting SARS-CoV-2 infection. A Mancon, A Rizzo, D Mileto, S Grosso, A Foschi, M Cutrera, et al. (+8)
172 [GO] 2022―Feb―24 Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation D Mileto, V Micheli, C Fenizia, M Cutrera, G Gagliardi, A Mancon, et al. (+6)
173 [GO] 2022―Feb―23 The Protection Provided by Naturally Acquired Antibodies against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis Qi Chen, Kongxin Zhu, Xiaohui Liu, Chunlan Zhuang, Xingcheng Huang, Yue Huang, et al. (+8)
174 [GO] 2022―Feb―21 The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year Xinrong Zhou, Lin Cheng, Haiyan Wang, Xuejiao Liao, Miao Wang, Lanlan Wei, et al. (+7)
175 [GO] 2022―Feb―18 Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant Xiaoling Yu, Xiangrong Qi, Yu Cao, Peiyao Li, Li Lu, Pingping Wang, et al. (+8)
176 [GO] 2022―Feb―16 Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein Sheng Jiang, Shuting Wu, Gan Zhao, Yue He, Xinrong Guo, Zhiyu Zhang, et al. (+4)
177 [GO] 2022―Feb―09 Cocirculation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong Kin-Hang Kok, Shuk-Ching Wong, Wan-Mui Chan, Wen Lei, Allen Wing-Ho Chu, Jonathan Daniel Ip, et al. (+12)
178 [GO] 2022―Feb―08 Plasma miRNA profile at COVID-19 onset predicts severity status and mortality Asier Fernández-Pato, Ana Virseda-Berdices, Salvador Resino, Pablo Ryan, Oscar Martínez-González, Felipe Peréz-García, et al. (+14)
179 [GO] 2022―Feb―04 Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: A test-negative case-control study Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, et al. (+10)
180 [GO] 2022―Feb―02 Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant Natasha N. Gaudreault, Konner Cool, Jessie D. Trujillo, Igor Morozov, David A. Meekins, Chester McDowell, et al. (+13)
181 [GO] 2022―Feb―02 CRISPR-based Assay Reveals SARS-CoV-2 RNA Dynamic Changes and Redistribution Patterns in Non-Human Primate Model Zhen Huang, Lili Zhang, Christopher J. Lyon, Bo Ning, Brady M. Youngquist, Alex Niu, et al. (+6)
182 [GO] 2022―Jan―29 Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques Fang Xu, Shipo Wu, Linan Yi, Shaodan Peng, Fan Wang, Weixue Si, et al. (+2)
183 [GO] 2022―Jan―27 Possible recombination between two variants of concern in a COVID-19 patient Yaqing He, Wentai Ma, Shengyuan Dang, Long Chen, Renli Zhang, Shujiang Mei, et al. (+16)
184 [GO] 2022―Jan―27 Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine Lin-Lei Chen, Gilbert T. Chua, Lu Lu, Brian Pui-Chun Chan, Joshua Sung-Chih Wong, Calvin Chit-Kwong Chow, et al. (+11)
185 [GO] 2022―Jan―21 Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents Chengbao Ma, Xianying Chen, Fanghua Mei, Qing Xiong, Qianyun Liu, Lianghui Dong, et al. (+14)
186 [GO] 2022―Jan―21 Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants Fengze Wang, Li Li, Yang Dou, Rui Shi, Xiaomin Duan, Hongchuan Liu, et al. (+8)
187 [GO] 2022―Jan―21 hnRNP C modulates MERS-CoV and SARS-CoV-2 replication by governing the expression of a subset of circRNAs and cognitive mRNAs Xi Zhang, Hin Chu, Kenn Ka-Hang Chik, Wen Lei, Huiping Shuai, Dong Yang, et al. (+8)
188 [GO] 2022―Jan―20 B cell Receptor Signatures Associating with Strong and Poor SARS-CoV-2 Vaccine Response Ke Lin, Yawen Zhou, Jingwen Ai, Yan A. Wang, Senxin Zhang, Chao Qiu, et al. (+23)
189 [GO] 2022―Jan―15 Homologous or Heterologous Booster of Inactivated Vaccine Reduces SARS-CoV-2 Omicron Variant Escape from Neutralizing Antibodies Xun Wang, Xiaoyu Zhao, Jieyu Song, Jing Wu, Yuqi Zhu, Minghui Li, et al. (+7)
190 [GO] 2022―Jan―10 Resistance of SARS-CoV-2 Omicron Variant to Convalescent and CoronaVac Vaccine Plasma Yingdan Wang, Yunping Ma, Yan Xu, Jiangyan Liu, Xiang Li, Yuyuan Chen, et al. (+6)
191 [GO] 2022―Jan―06 Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in mouse model Yanxia Chen, Can Li, Feifei Liu, Zhanhong Ye, Wenchen Song, Andrew C.Y. Lee, et al. (+7)
192 [GO] 2022―Jan―06 Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro Binli Mao, Vu Thuy Khanh Le-Trilling, Kai Wang, Denise Mennerich, Jie Hu, Zhenyu Zhao, et al. (+13)
193 [GO] 2022―Jan―05 Genetic analysis of a SARS-CoV-2 Omicron variant from a Chinese traveler returning from overseas Hongling Jia, Hui Wang, Lan Cao, Zhisheng Lai, Zichun Cheng, Qingpei Chen, et al. (+10)
194 [GO] 2021―Dec―29 Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein Shiqi Xu, Yifan Wang, Yanxing Wang, Chao Zhang, Qin Hong, Chenjian Gu, et al. (+17)
195 [GO] 2021―Dec―28 Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients Kwang-Soo Lyoo, Hyeon Myeong Kim, Bina Lee, Young Hyun Che, Seong-Jae Kim, Daesub Song, et al. (+6)
196 [GO] 2021―Dec―24 SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with delta variant in TMPRSS2-expressed cells Hanjun Zhao, Lu Lu, Zheng Peng, Lin-Lei Chen, Xinjin Meng, Chuyuan Zhang, et al. (+8)
197 [GO] 2021―Dec―24 A New Testing Platform Using Fingerstick Blood for Quantitative Antibody Response Evaluation after SARS-CoV-2 Vaccination Jinwei Du, Dayu Zhang, Joseph A. Pathakamuri, Daniel Kuebler, Ying Yang, Yulia Loginova, et al. (+10)
198 [GO] 2021―Dec―22 COVID-19 prevention measures reduce dengue spread in Yunnan Province, China, but do not reduce established outbreak Z.Y. Sheng, M. Li, R. Yang, Y.H. Liu, X.X. Yin, J. R. Mao, et al. (+4)
199 [GO] 2021―Dec―22 Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost Jingwen Ai, Haocheng Zhang, Yi Zhang, Ke Lin, Yanliang Zhang, Jing Wu, et al. (+16)
200 [GO] 2021―Dec―21 Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract Manel Essaidi-Laziosi, Catia Alvarez, Olha Puhach, Pascale Sattonnet-Roche, Giulia Torriani, Caroline Tapparel, et al. (+2)
201 [GO] 2021―Dec―21 Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants Shengtao Fan, Kang Xiao, Dandan Li, Heng Zhao, Jingjing Zhang, Li Yu, et al. (+21)
202 [GO] 2021―Dec―17 Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains in the Arabian Peninsula Nigeer Te, Jordi Rodon, Mónica Pérez, Joaquim Segalés, Júlia Vergara-Alert, Albert Bensaid
203 [GO] 2021―Dec―15 Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China Zhaoyong Zhang, Wenkuan Liu, Shengnan Zhang, Peilan Wei, Lu Zhang, Dehui Chen, et al. (+7)
204 [GO] 2021―Dec―11 The significant immune escape of pseudotyped SARS-CoV-2 Variant Omicron Li Zhang, Qianqian Li, Ziteng Liang, Tao Li, Shuo Liu, Qianqian Cui, et al. (+5)
205 [GO] 2021―Dec―03 A second functional furin site in the SARS-CoV-2 spike protein Yue Zhang, Li Zhang, Jiajing Wu, Yuanling Yu, Shuo Liu, Tao Li, et al. (+8)
206 [GO] 2021―Nov―29 Outcomes of Patients with Severe and Critical COVID-19 Treated with Dexamethasone: a Prospective Cohort Study Bernardo A. Martinez-Guerra, Maria F. Gonzalez-Lara, Carla M. Roman-Montes, Karla M. Tamez-Torres, Francisco E. Dardón-Fierro, Sandra Rajme-Lopez, et al. (+5)
207 [GO] 2021―Nov―29 Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer Konner Cool, Natasha N. Gaudreault, Igor Morozov, Jessie D. Trujillo, David A. Meekins, Chester McDowell, et al. (+14)
208 [GO] 2021―Nov―29 Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands Reina S. Sikkema, Tijs Tobias, Nadia Oreshkova, Erwin de Bruin, Nisreen Okba, Felicity Chandler, et al. (+15)
209 [GO] 2021―Nov―29 A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain) Cristina Andrés, Maria Piñana, Blanca Borras-Bermejo, Alejandra González-Sánchez, Damir García-Cehic, Juliana Esperalba, et al. (+15)
210 [GO] 2021―Nov―27 A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, et al. (+11)
211 [GO] 2021―Nov―24 Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination Meiyu Wang, Li Zhang, Qianqian Li, Bo Wang, Ziteng Liang, Yeqing Sun, et al. (+7)
212 [GO] 2021―Nov―18 Isolation of 4000 SARS-CoV-2 shows that contagiousness is associated with viral load, not vaccine or symptomatic status Celine Boschi, Sarah Aherfi, Linda Houhamdi, Philippe Colson, Didier Raoult, Bernard La Scola
213 [GO] 2021―Nov―16 A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality. Serge Camelo, Mathilde Latil, Sam Agus, Waly Dioh, Stanislas Veillet, René Lafont, Pierre J. Dilda
214 [GO] 2021―Nov―16 Identification of the SARS-CoV-2 Delta variant C22995A using a high-resolution melting curve RT-FRET-PCR Subarna Barua, Jianfa Bai, Patrick John Kelly, Gregg Hanzlicek, Lance Noll, Calvin Johnson, et al. (+2)
215 [GO] 2021―Nov―09 Susceptibility of livestock to SARS-CoV-2 infection Angela M. Bosco-Lauth, Audrey Walker, Lauren Guilbert, Stephanie Porter, Airn Hartwig, Emma McVicker, et al. (+2)
216 [GO] 2021―Nov―09 SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response D Mileto, C Fenizia, M Cutrera, G Gagliardi, A Gigantiello, A. De Silvestri, et al. (+15)
217 [GO] 2021―Nov―05 Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models Dandan Li, Ning Luan, Jing Li, Heng Zhao, Ying Zhang, Runxiang Long, et al. (+10)
218 [GO] 2021―Nov―01 Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021 Carlo Casanova, Marianne Küffer, Stephen L. Leib, Markus Hilty
219 [GO] 2021―Oct―28 Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men Nina Le Bert, Wan Ni Chia, Wei Yee Wan, Alvin Kuo Jing Teo, Samuel Zeng-Rong Chong, Nicole Tan, et al. (+27)
220 [GO] 2021―Oct―25 Saliva specimen complements anal swab in assessing patients with COVID-19 for discharge from hospital Chenghao Qiu, Zhigang Song, Jing Wang, Cheng Tian, Xingzhe Liu, Tingting Wu, et al. (+3)
221 [GO] 2021―Oct―21 Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern Lei Yue, Jian Zhou, Yanan Zhou, Xiaolei Yang, Tianhong Xie, Mengli Yang, et al. (+12)
222 [GO] 2021―Oct―17 One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization Maggie Gu, Jonathan L. Torres, Yijia Li, Alex Van Ry, Jack Greenhouse, Shannon Wallace, et al. (+8)
223 [GO] 2021―Oct―17 SPIKE PROTEIN EVOLUTION IN THE SARS-CoV-2 DELTA VARIANT OF CONCERN: A CASE SERIES FROM NORTHERN LOMBARDY Andreina Baj, Federica Novazzi, Francesca Drago Ferrante, Angelo Genoni, Elena Tettamanzi, Giuseppe Catanoso, et al. (+4)
224 [GO] 2021―Sep―20 Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses Belén Aparicio, Noelia Casares, Josune Egea, Marta Ruiz, Diana Llopiz, Sheila Maestro, et al. (+11)
225 [GO] 2021―Sep―07 SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications Lunzhi Yuan, Qiyi Tang, Huachen Zhu, Yi Guan, Tong Cheng, Ningshao Xia
226 [GO] 2021―Aug―24 Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies Liubov I. Kozlovskaya, Anastasia N. Piniaeva, Georgy M. Ignatyev, Ilya V. Gordeychuk, Viktor P. Volok, Yulia V. Rogova, et al. (+24)
227 [GO] 2021―Aug―17 Host-dependent editing of SARS-CoV-2 in COVID-19 patients Josep Gregori, Maria Francesca Cortese, Maria Piñana, Carolina Campos, Damir Garcia-Cehic, Cristina Andrés, et al. (+15)
228 [GO] 2021―Aug―17 High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study. Maria Schroeder, Berfin Schaumburg, Zacharias Mueller, Ann Parplys, Dominik Jarczak, Kevin Roedl, et al. (+19)
229 [GO] 2021―Aug―14 Efficacy of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: A test-negative case-control real-world study Xiao-ning Li, Yong Huang, Wen Wang, Qin-long Jing, Chun-huan Zhang, Peng-zhe Qin, et al. (+10)
230 [GO] 2021―Aug―10 Antibodies to SARS-CoV-2 in dogs and cats, USA Subarna Barua, Monirul Hoque, Folasade Adekanmbi, Patrick Kelly, Melinda Jenkins-Moore, Mia Kim Torchetti, et al. (+3)
231 [GO] 2021―Aug―09 Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice Zhen Zhang, Qianyun Liu, Ying Sun, Jiali Li, Jiejie Liu, Ruangang Pan, et al. (+9)
232 [GO] 2021―Aug―05 A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China Li-li Li, Jing-lin Wang, Xiao-hua Ma, Xiao-man Sun, Jin-song Li, Xiao-fei Yang, et al. (+2)
233 [GO] 2021―Aug―05 Epidemiological and co-infection characteristics of common human coronaviruses in Shanghai, 2015-2020: a retrospective observational study Dechuan Kong, Yaxu Zheng, Linjie Hu, Jian Chen, Huanyu Wu, Zheng Teng, et al. (+4)
234 [GO] 2021―Aug―04 Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: A Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody Xianmin Meng, Peipei Wang, Yanqing Xiong, Yijun Wu, Xiaoyan Lin, Song Lu, et al. (+11)
235 [GO] 2021―Jul―26 A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge Xiangchuan He, Longfei Ding, Kangli Cao, Haoran Peng, Chenjian Gu, Yutang Li, et al. (+17)
236 [GO] 2021―Jul―22 Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19 Kun Xu, Yaling An, Qunlong Li, Weijin Huang, Yuxuan Han, Tianyi Zheng, et al. (+17)
237 [GO] 2021―Jul―19 Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, et al. (+13)
238 [GO] 2021―Jul―19 Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants Wenbo Wang, Qianqian Li, Jiajing Wu, Yu Hu, Gang Wu, Chuanfei Yu, et al. (+6)
239 [GO] 2021―Jul―16 The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany Theo Dähne, Wolfgang Bauer, Andreas Essig, Bernhard Schaaf, Christoph D. Spinner, Mathias W. Pletz, et al. (+4)
240 [GO] 2021―Jul―15 Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor Hua Guo, Ben Hu, Hao-rui Si, Yan Zhu, Wei Zhang, Bei Li, et al. (+6)
241 [GO] 2021―Jul―01 Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: A randomised, double-blind, placebo-controlled, phase I trial Yuyi Liao, Yuan Li, Rongjuan Pei, Xin Fang, Peiyu Zeng, Renfeng Fan, et al. (+13)
242 [GO] 2021―Jun―29 Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil Fernando Hayashi Sant’Anna, Ana Paula Muterle Varela, Janira Prichula, Juliana Comerlato, Carolina Baldisserotto Comerlato, Vinicius Serafini Roglio, et al. (+4)
243 [GO] 2021―Jun―28 Metagenomic next-generation sequencing in the family outbreak of psittacosis: First reported family outbreak of psittacosis in China under COVID-19 Na Li, Shengjin Li, Wanmei Tan, Hanghang Wang, Huan Xu, Daoxing Wang
244 [GO] 2021―Jun―28 Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2 Claudia Gonzalez, Carla Saade, Antonin Bal, Martine Valette, Kahina Saker, Bruno Lina, et al. (+11)
245 [GO] 2021―Jun―14 Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations Lishuang Shen, Jennifer Dien Bard, Timothy J. Triche, Alexander R. Judkins, Jaclyn A. Biegel, Xiaowu Gai
246 [GO] 2021―Jun―14 Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, Robert J. Fischer, Jonathan E. Schulz, Myndi G. Holbrook, et al. (+4)
247 [GO] 2021―Jun―14 Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination Yuxin Chen, Liguo Zhu, Weijin Huang, Xin Tong, Hai Wu, Yue Tao, et al. (+6)
248 [GO] 2021―Jun―10 SYMPTOMATIC SARS-CoV-2 INFECTIONS AFTER FULL SCHEDULE BNT162b2 VACCINATION IN SEROPOSITIVE HEALTHCARE WORKERS: A CASE SERIES FROM A SINGLE INSTITUTION Andreina Baj, Federica Novazzi, Angelo Genoni, Francesca Drago Ferrante, Stefano Taborelli, Beatrice Pini, et al. (+9)
249 [GO] 2021―Jun―07 Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants Alberto Zani, Francesca Caccuri, Serena Messali, Carlo Bonfanti, Arnaldo Caruso
250 [GO] 2021―Jun―02 H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice Heng Li, Xin Zhao, Yurong Zhao, Jing Li, Huiwen Zheng, Mengyi Xue, et al. (+10)
251 [GO] 2021―May―31 Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants Danwei Yu, Yuanmei Zhu, Tao Jiao, Tong Wu, Xia Xiao, Bo Qin, et al. (+7)
252 [GO] 2021―May―29 Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine Yun Liao, Ying Zhang, Heng Zhao, Jing Pu, Zhimei Zhao, Dandan Li, et al. (+7)
253 [GO] 2021―May―29 Intra-species sialic acid polymorphism in humans: a common niche for influenza and coronavirus pandemics? Xi Jiang, Ming Tan, Ming Xia, Pengwei Huang, Michael A. Kennedy
254 [GO] 2021―May―21 Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR Laura Amato, Lucija Jurisic, Ilaria Puglia, Valeria Di Lollo, Valentina Curini, Giuseppe Torzi, et al. (+8)
255 [GO] 2021―May―20 Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate. Endika Prieto-Fernández, Leire Egia-Mendikute, Laura Vila-Vecilla, Alexandre Bosch, Adrián Barreira-Manrique, So Young Lee, et al. (+8)
256 [GO] 2021―May―18 Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients Xiaohui Wang, Joy-Yan Lam, Linlei Chen, Shannon Wing-Ngor Au, Kelvin K. W. To, Kwok-Yung Yuen, Kin-Hang Kok
257 [GO] 2021―May―17 Prime-boost vaccination of mice and Rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates Shengxue Luo, Panli Zhang, Bochao Liu, Chan Yang, Chaolan Liang, Qi Wang, et al. (+10)
258 [GO] 2021―May―17 The COVID-19-designated hospitals in China: Preparing for public health emergencies Qian Li, Lin Wang, Bangfang Wang, Hongzhou Lu
259 [GO] 2021―May―12 A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations Yanan Zhao, Annie Lee, Kaelea Composto, Marcus H. Cunningham, Jose R. Mediavilla, Samantha Fennessey, et al. (+6)
260 [GO] 2021―May―05 Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients Qihong Yan, Ping He, Xiaohan Huang, Kun Luo, Yudi Zhang, Haisu Yi, et al. (+18)
261 [GO] 2021―May―02 A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter Wen-Yang Tsai, Lauren L. Ching, Szu-Chia Hsieh, Marian E. Melish, Vivek R. Nerurkar, Wei-Kung Wang
262 [GO] 2021―Apr―26 Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications Lishuang Shen, Jennifer Dien Bard, Timothy J. Triche, Alexander R. Judkins, Jaclyn A. Biegel, Xiaowu Gai
263 [GO] 2021―Apr―23 A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters Bao-Zhong Zhang, Xiaolei Wang, Shuofeng Yuan, Wenjun Li, Ying Dou, Vincent Kwok-Man Poon, et al. (+19)
264 [GO] 2021―Apr―19 Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses Yong Yang, Xi Wang, Rong-Hui Du, Wei Zhang, Hao-Rui Si, Yan Zhu, et al. (+10)
265 [GO] 2021―Apr―08 Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort Alexandra Rockstroh, Johannes Wolf, Jasmin Fertey, Sven Kalbitz, Stefanie Schroth, Christoph Lübbert, et al. (+2)
266 [GO] 2021―Mar―19 INTRODUCTION OF SARS-COV-2 VARIANT OF CONCERN 20H/501Y.V2 (B.1.351) FROM MALAWI TO ITALY Federica Novazzi, Angelo Genoni, Pietro Giorgio Spezia, Daniele Focosi, Cristian Zago, Alberto Colombo, et al. (+14)
267 [GO] 2021―Mar―18 Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients:a retrospective study Li Guo, Yeming Wang, Liang Kang, Yongfeng Hu, Linghang Wang, Jingchuan Zhong, et al. (+16)
268 [GO] 2021―Mar―11 Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients Nannan Wu, Jia Dai, Mingquan Guo, Jianhui Li, Xin Zhou, Feng Li, et al. (+28)
269 [GO] 2021―Mar―11 Heterologous prime-boost: Breaking the protective immune response bottleneck of COVID-19 vaccine candidates Qian He, Qunying Mao, Chaoqiang An, Jialu Zhang, Fan Gao, Lianlian Bian, et al. (+4)
270 [GO] 2021―Mar―11 Experimental re-infected cats do not transmit SARS-CoV-2 Natasha N. Gaudreault, Mariano Carossino, Igor Morozov, Jessie D. Trujillo, David A. Meekins, Daniel W. Madden, et al. (+13)
271 [GO] 2021―Mar―11 Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers Javier Martínez-Sanz, Daniel Jiménez, Laura Martínez-Campelo, Raquel Cruz, Pilar Vizcarra, Matilde Sánchez-Conde, et al. (+6)
272 [GO] 2021―Mar―11 The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract Yuejun Shi, Lei Shuai, Zhiyuan Wen, Chong Wang, Yan Yuanyuan, Zhe Jiao, et al. (+5)
273 [GO] 2021―Mar―05 Lessons learned one year after SARS-CoV-2 emergence leading to COVID-19 pandemic Kelvin Kai-Wang To, Siddharth Sridhar, Kelvin Hei-Yeung Chiu, Derek Ling-Lung Hung, Xin Li, Ivan Fan-Ngai Hung, et al. (+6)
274 [GO] 2021―Feb―26 Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants Shan Su, Yiming Shao, Shibo Jiang
275 [GO] 2021―Feb―14 The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor Yanmei Hu, Xiangzhi Meng, Fushun Zhang, Yan Xiang, Jun Wang
276 [GO] 2021―Feb―13 A Novel DNA and Protein Combination COVID-19 Vaccine Formulation Provides Full Protection against SARS-CoV-2 in Rhesus Macaques Yuzhong Li, Yanwei Bi, Hongjian Xiao, Yueting Yao, Xiaojuan Liu, Zhengrong Hu, et al. (+17)
277 [GO] 2021―Feb―05 Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection Zi-Wei Ye, Shuofeng Yuan, Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Ching-Yun Yu, Chon Phin Ong, et al. (+10)
278 [GO] 2021―Feb―02 Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein Serena Delbue, Sarah D’Alessandro, Lucia Signorini, Maria Dolci, Elena Pariani, Michele Bianchi, et al. (+5)
279 [GO] 2021―Feb―01 COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue Yongzhi Xi
280 [GO] 2021―Jan―20 Saliva Viral Load Better Correlates with Clinical and Immunological Profiles in Children with Coronavirus Disease 2019 Gilbert T Chua, Joshua SC Wong, Kelvin KW To, Polly PK Ho, Ivan CS Lam, Jaime SR Duque, et al. (+16)
281 [GO] 2021―Jan―07 Novel Dual Multiplex Real-time RT-PCR Assays for the Rapid Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus using the BD Max Open System Hsing-Yi Chung, Ming-Jr Jian, Chih-Kai Chang, Jung-Chung Lin, Kuo-Ming Yeh, Chien-Wen Chen, et al. (+11)
282 [GO] 2021―Jan―07 Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission Young-Il Kim, Se-Mi Kim, Su-Jin Park, Eun-Ha Kim, Kwang-Min Yu, Jae-Hyung Chang, et al. (+18)
283 [GO] 2021―Jan―05 The interplay between emerging human coronavirus infections and autophagy Zhenyu Zhao, Kefeng Lu, Binli Mao, Shi Liu, Mirko Trilling, Ailong Huang, et al. (+2)
284 [GO] 2021―Jan―05 Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials Elena Criscuolo, Roberta A. Diotti, Roberto Ferrarese, Cesare Alippi, Gabriele Viscardi, Carlo Signorelli, et al. (+3)
285 [GO] 2021―Jan―05 Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France Grégory Quéromès, Grégory Destras, Antonin Bal, Hadrien Regue, Gwendolyne Burfin, Solenne Brun, et al. (+7)
286 [GO] 2020―Dec―29 SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Mehdi Moustaqil, Emma Ollivier, Hsin-Ping Chiu, Sarah Van Tol, Paulina Rudolffi-Soto, Christian Stevens, et al. (+7)
287 [GO] 2020―Dec―23 Susceptibility of rabbits to SARS-CoV-2 Anna Z. Mykytyn, Mart M. Lamers, Nisreen M.A. Okba, Tim I. Breugem, Debby Schipper, Petra B. van den Doel, et al. (+7)
288 [GO] 2020―Dec―17 Structure of the Multiple Functional Domains from Coronavirus Nonstructural Protein 3 Mengxia Li, Gang Ye, Yu Si, Zhou Shen, Zhu Liu, Yuejun Shi, et al. (+3)
289 [GO] 2020―Dec―15 A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners. Víctor Neira, Bárbara Brito, Belén Agüero, Felipe Berrios, Valentina Valdés, Alberto Gutierrez, et al. (+16)
290 [GO] 2020―Dec―12 SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay Victoria Elizondo, Gordon W. Harkins, Batsirai Mabvakure, Sabine Smidt, Paul Zappile, Christian Marier, et al. (+19)
291 [GO] 2020―Dec―10 An infectious cDNA clone of a growth attenuated Korean isolate of MERS coronavirus KNIH002 in clade B Minwoo Kim, Hee Cho, Seung-Hoon Lee, Woo-Jung Park, Jeong-Min Kim, Jae-Su Moon, et al. (+8)
292 [GO] 2020―Dec―01 High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients Haibo Li, Lili Ren, Lulu Zhang, Yeming Wang, Li Guo, Conghui Wang, et al. (+12)
293 [GO] 2020―Dec―01 Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens DM Favara, ML Ceron-Gutierrez, GW Carnell, JL Heeney, P Corrie, R Doffinger
294 [GO] 2020―Nov―30 Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection Kyle Rosenke, Kimberly Meade-White, Michael Letko, Chad Clancy, Frederick Hansen, Yanan Liu, et al. (+10)
295 [GO] 2020―Nov―26 Low Toxicity and High Immunogenicity of an Inactivated Vaccine Candidate against COVID-19 in different animal models Ze-Jun Wang, Hua-Jun Zhang, Jia Lu, Kang-Wei Xu, Cheng Peng, Jing Guo, et al. (+32)
296 [GO] 2020―Nov―24 Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate Xiao-Yu Zhang, Jing Guo, Xin Wan, Jin-Ge Zhou, Wei-Ping Jin, Jia Lu, et al. (+11)
297 [GO] 2020―Nov―18 Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong? Gilman Kit-Hang SIU, Lam-Kwong LEE, Kenneth Siu-Sing LEUNG, Jake Siu-Lun LEUNG, Timothy Ting-Leung NG, Chloe Toi-Mei CHAN, et al. (+16)
298 [GO] 2020―Nov―18 Low incidence of airborne SARS-CoV-2 in acute care hospital rooms with optimized ventilation Nathan Dumont-Leblond, Marc Veillette, Samira Mubareka, Lily Yip, Yves Longtin, Philippe Jouvet, et al. (+6)
299 [GO] 2020―Nov―18 A Lateral Flow Immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers. Ronan Garlantézec, Christopher Heslan, Emilie Tadie, Pierre Tattevin, Vincent Thibault, Christophe Paris
300 [GO] 2020―Nov―18 Loss of orf3b in the circulating SARS-CoV-2 strains Joy-Yan Lam, Chun-Kit Yuen, Jonathan Daniel Ip, Wan-Man Wong, Kelvin Kai-Wang To, Kwok-Yung Yuen, Kin-Hang Kok
301 [GO] 2020―Nov―16 Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19 Qian Li, Xiao-Shuang Zheng, Xu-Rui Shen, Hao-Rui Si, Xi Wang, Qi Wang, et al. (+10)
302 [GO] 2020―Nov―12 Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target Cun Li, Hin Chu, Xiaojuan Liu, Man Chun Chiu, Xiaoyu Zhao, Dong Wang, et al. (+7)
303 [GO] 2020―Nov―09 Excretion of SARS-CoV-2 through faecal specimens Yong Zhang, Cao Chen, Yang Song, Shuangli Zhu, Dongyan Wang, Hui Zhang, et al. (+14)
304 [GO] 2020―Nov―03 COVID-19 In Children Across Three Asian Cosmopolitan Regions Gilbert T. Chua, Xiaoli Xiong, Eun Hwa Choi, Mi Seon Han, Sung Hee Chang, Byoung Lo Jin, et al. (+48)
305 [GO] 2020―Nov―02 Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal Vítor Borges, Joana Isidro, Helena Cortes-Martins, Sílvia Duarte, Luís Vieira, Ricardo Leite, et al. (+7)
306 [GO] 2020―Oct―30 The Values and Limitations of Mathematical Modeling to COVID-19 in the World: A Follow Up Report Yuanji Tang, Sherry Tang, Shixia Wang
307 [GO] 2020―Oct―17 Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection Raveen Rathnasinghe, Shirin Strohmeier, Fatima Amanat, Virginia L. Gillespie, Florian Krammer, Adolfo García-Sastre, et al. (+3)
308 [GO] 2020―Oct―16 A Timely Update of Global COVID-19 Vaccine Development Linda Klavinskis, Margaret Liu, Shan Lu
309 [GO] 2020―Oct―15 Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital Qi Wang, Xiaotao Zhao, Zhihong Yue, Xiaohui Bai, Huiying Rao, Na Han, et al. (+3)
310 [GO] 2020―Oct―14 A multi-family cluster of COVID-19 associated with asymptomatic and pre-symptomatic transmission in Jixi City, Heilongjiang, China, 2020 Hongyang Zhang, Chengcheng Hong, Qulu Zheng, Pengzheng Zhou, Yuliang Zhu, Zhongkai Zhang, et al. (+2)
311 [GO] 2020―Oct―14 Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study Chao Yang, Min Jiang, Xiaohui Wang, Xiujuan Tang, Shisong Fang, Hao Li, et al. (+29)
312 [GO] 2020―Oct―14 A SARS-CoV-2 variant with the 12-bp deletion at E gene Yi-Sheng Sun, Fang Xu, Qi An, Chen Chen, Zhang-Nv Yang, Hang-Jing Lu, et al. (+4)
313 [GO] 2020―Oct―12 Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralisation Test (sVNT) Benjamin Meyer, Johan Reimerink, Giulia Torriani, Fion Brouwer, Gert-Jan Godeke, Sabine Yerly, et al. (+5)
314 [GO] 2020―Oct―08 SARS-CoV-2 infection, disease and transmission in domestic cats Natasha N. Gaudreault, Jessie D. Trujillo, Mariano Carossino, David A. Meekins, Igor Morozov, Daniel W. Madden, et al. (+12)
315 [GO] 2020―Oct―02 Susceptibility of swine cells and domestic pigs to SARS-CoV-2 David A. Meekins, Igor Morozov, Jessie D. Trujillo, Natasha N. Gaudreault, Dashzeveg Bold, Mariano Carossino, et al. (+10)
316 [GO] 2020―Sep―29 Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays Hongyue Li, Chaoyue Zhao, Yuhang Zhang, Fei Yuan, Qi Zhang, Xuanling Shi, et al. (+3)
317 [GO] 2020―Sep―28 Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness Ke Hong, Wei Cao, Zhengyin Liu, Ling Lin, Xing Zhou, Yan Zeng, et al. (+6)
318 [GO] 2020―Sep―24 Zoonotic and Reverse Zoonotic Events of SARS-CoV-2 and their Impact on Global Health Khalid Munir, Shoaib Ashraf, Isra Munir, Hamna Khalid, Mohammad Akram Muneer, Noreen Mukhtar, et al. (+9)
319 [GO] 2020―Sep―24 Rapid Determination of SARS-CoV-2 Antibodies Using a Bedside, Point-of-Care, Serological Test Laurent Dortet, Cecile Emeraud, Christelle Vauloup-Fellous, Mouna Khecharem, Jean-Baptiste Ronat, Nicolas Fortineau, et al. (+2)
320 [GO] 2020―Sep―24 Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells Sunhee Lee, Gun Young Yoon, Jinjong Myoung, Seong-Jun Kim, Dae-Gyun Ahn
321 [GO] 2020―Sep―23 Meta-analysis of Diagnostic Performance of Serology Tests for COVID-19: Impact of Assay Design and Post-symptom-onset Intervals Hongyu Wang, Jingwen Ai, Michael J. Loeffelholz, Yi-Wei Tang, Wenhong Zhang
322 [GO] 2020―Sep―17 Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan Shey-Ying Chen, Yu-Lin Lee, Yi-Chun Lin, Nan-Yao Lee, Chia-Hung Liao, Yuan-Pin Hung, et al. (+16)
323 [GO] 2020―Sep―17 Short- and Potential Long-term Adverse Health Outcomes of COVID-19: A Rapid Review TYM Leung, AYL Chan, EW Chan, VYK Chan, CSL Chui, BJ Cowling, et al. (+19)
324 [GO] 2020―Sep―15 SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease Pengfei Wang, Lihong Liu, Manoj S. Nair, Michael T. Yin, Yang Luo, Qian Wang, et al. (+12)
325 [GO] 2020―Sep―08 SARS-CoV-2 spike produced in insect cells elicits high neutralization titers in non-human primates Tingting Li, Qingbing Zheng, Hai Yu, Dinghui Wu, Wenhui Xue, Hualong Xiong, et al. (+20)
326 [GO] 2020―Sep―07 Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells Hua-Long Xiong, Yang-Tao Wu, Jia-Li Cao, Ren Yang, Ying-Xia Liu, Jian Ma, et al. (+18)
327 [GO] 2020―Sep―01 A serological survey of SARS-CoV-2 in cat in Wuhan Qiang Zhang, Huajun Zhang, Jindong Gao, Kun Huang, Yong Yang, Xianfeng Hui, et al. (+11)
328 [GO] 2020―Sep―01 SARS-CoV-2 infection: diagnostic testing results occasionally require special attention Elisabetta Riva, Pier Paolo Sainaghi, Ombretta Turriziani, Guido Antonelli, Giuseppe Patti
329 [GO] 2020―Aug―26 Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population Zhigang Yi, Yun Ling, Xiaonan Zhang, Jieliang Chen, Kongying Hu, Yuyan Wang, et al. (+5)
330 [GO] 2020―Aug―21 Accurate Serology for SARS-CoV-2 and common Human Coronaviruses using a Multiplex Approach Sophie van Tol, Ramona Mögling, Wentao Li, Gert-Jan Godeke, Arno Swart, Barbara Bergmans, et al. (+8)
331 [GO] 2020―Aug―20 Risks and features of secondary infections in severe and critical ill COVID-19 patients Haocheng Zhang, Yi Zhang, Jing Wu, Yang Li, Xian Zhou, Xin Li, et al. (+9)
332 [GO] 2020―Aug―19 Establishing A High Sensitivity Detection Method for SARS-CoV-2 IgM/IgG and Developing a Clinical Application of this Method Chunyan Zhang, Lei Zhou, Hao Liu, Sibing Zhang, Yaping Tian, Junli Huo, et al. (+18)
333 [GO] 2020―Aug―14 Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicenter, proof-of-concept, observational study. Yang Li, Xian Zhou, Tao Li, Shiji Chan, Yiqi Yu, Jing-Wen Ai, et al. (+7)
334 [GO] 2020―Aug―13 Dynamic changes of throat swabs RNA and serum antibodies for SARS-CoV-2 and their diagnostic performances in patients with COVID-19 Xueping Qiu, Yang Xiang, Jianbin Sun, Xinrui Wang, Guoqiang Chen, Xianqun Xu, et al. (+10)
335 [GO] 2020―Aug―05 Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients Cristina Andres, Damir Garcia-Cehic, Josep Gregori, Maria Piñana, Francisco Rodriguez-Frias, Mercedes Guerrero-Murillo, et al. (+13)
336 [GO] 2020―Jul―29 The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing Joilson Xavier, Marta Giovanetti, Talita Adelino, Vagner Fonseca, Alana Vitor Barbosa da Costa, Adriana Aparecida Ribeiro, et al. (+22)
337 [GO] 2020―Jul―29 Status of Occupational Protection in the COVID-19 Fangcang Shelter Hospital in Wuhan, China Min Zhang, Lili Wang, Siyuan Yu, Guixin Sun, Han Lei, Wenjuan Wu
338 [GO] 2020―Jul―21 Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells Sofia Appelberg, Soham Gupta, Sara Svensson Akusjärvi, Anoop T Ambikan, Flora Mikaeloff, Elisa Saccon, et al. (+9)
339 [GO] 2020―Jul―16 Rapid inactivation of SARS-CoV-2 with Deep-UV LED irradiation Hiroko Inagaki, Akatsuki Saito, Hironobu Sugiyama, Tamaki Okabayashi, Shouichi Fujimoto
340 [GO] 2020―Jul―13 Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection Dorothea Orth-Höller, Angelika Eigentler, Lukas Weseslindtner, Johannes Möst
341 [GO] 2020―Jul―03 High neutralizing antibody titer in intensive care unit patients with COVID-19 Li Liu, Kelvin Kai-Wang To, Kwok-Hung Chan, Yik-Chun Wong, Runhong Zhou, Ka-Yi Kwan, et al. (+10)
342 [GO] 2020―Jul―03 Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry Peng Xu, Xiangyu Xing, Keying Yu, Zhiguo Lv, Huijing Cui, Yuhang Shi, et al. (+12)
343 [GO] 2020―Jul―03 Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines Lucia Grenga, Fabrice Gallais, Olivier Pible, Jean-Charles Gaillard, Duarte Gouveia, Hélène Batina, et al. (+14)
344 [GO] 2020―Jul―01 Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing Tao Liu, Wenjia Liang, Haojie Zhong, Jianfeng He, Zihui Chen, Guanhao He, et al. (+26)
345 [GO] 2020―Jul―01 Retrospective detection of SARS-CoV-2 in hospitalized patients with influenza-like illness Xiaoqi Yu, Dong Wei, Yongyan Chen, Donghua Zhang, Xinxin Zhang
346 [GO] 2020―Jun―30 Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion Mei Zheng, Xuesen Zhao, Shuangli Zheng, Danying Chen, Pengcheng Du, Xinglin Li, et al. (+4)
347 [GO] 2020―Jun―24 Organising a COVID-19 Triage Unit: a Swiss Perspective Georgios Peros, Ferda Gronki, Nadine Molitor, Michael Streit, Kiyoshi Sugimoto, Urs Karrer, et al. (+4)
348 [GO] 2020―Jun―23 Epidemiology and clinical course of COVID-19 in Shanghai, China Yinzhong Shen, Fang Zheng, Danfeng Sun, Yun Ling, Jun Chen, Feng Li, et al. (+18)
349 [GO] 2020―Jun―23 Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? Jean-Marie Berthelot, Ludovic Drouet, Frédéric Lioté
350 [GO] 2020―Jun―23 Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey Pia Paffenholz, Arne Peine, Martin Hellmich, Stella V. Paffenholz, Lukas Martin, Mark L, et al. (+7)
351 [GO] 2020―Jun―18 Antibodies in the breast milk of a maternal woman with COVID-19 Yunzhu Dong, Xiangyang Chi, Hai Huang, Liangliang Sun, Mengyao Zhang, Wei-Fen Xie, Wei Chen
352 [GO] 2020―Jun―18 Epidemiology of COVID-19 in Brazil: using a mathematical model to estimate the outbreak peak and temporal evolution Yuanji Tang, Tamires D. A. Serdan, Laureane N. Masi, Sherry Tang, Renata Gorjao, Sandro M. Hirabara
353 [GO] 2020―Jun―18 Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing Fabiola Mancini, Fabrizio Barbanti, Maria Scaturro, Giulia Errico, Angelo Iacobino, Antonino Bella, et al. (+6)
354 [GO] 2020―Jun―16 Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site Xi Jin, Kangli Xu, Penglei Jiang, Jiangshan Lian, Shaorui Hao, Hangping Yao, et al. (+30)
355 [GO] 2020―Jun―16 Development of an automatic integrated gene detection system for novel Severe acute respiratory syndrome-related coronavirus (SARS-CoV 2) Yuchang Li, Jing Li, Ying Zhang, Lizhong Dai, Lin Li, Juan Liu, et al. (+6)
356 [GO] 2020―Jun―16 SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East Yu-Nong Gong, Kuo-Chien Tsao, Mei-Jen Hsiao, Chung-Guei Huang, Peng-Nien Huang, Po-Wei Huang, et al. (+14)
357 [GO] 2020―Jun―15 The burden, admission, and outcome of COVID-19 in Africa: protocol for a systematic review and meta-analysis Degena Bahrey Tadesse, Gebreamlak Gebremedhn Gebremeskel, Guesh Gebreayezgi Asefa, Mebrahtu Abay, Gebre Teklemariam Demoz
358 [GO] 2020―Jun―12 Serological differentiation between COVID-19 and SARS infections Wan Ni Chia, Chee Wah Tan, Randy Foo, Adrian Eng Zheng Kang, Yilong Peng, Velraj Sivalingam, et al. (+9)
359 [GO] 2020―Jun―12 SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists Chun-Kit Yuen, Joy-Yan Lam, Wan-Man Wong, Long-Fung Mak, Xiaohui Wang, Hin Chu, et al. (+6)
360 [GO] 2020―Jun―11 Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries Xuemei Yang, Ning Dong, Edward Wai-Chi Chan, Sheng Chen
361 [GO] 2020―Jun―09 Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19 Pengcheng Liu, Jiehao Cai, Ran Jia, Shuai Xia, Xiangshi Wang, Lingfeng Cao, et al. (+2)
362 [GO] 2020―Jun―09 Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China Xu-hui Liu, Shui-hua Lu, Jun Chen, Lu Xia, Zong-guo Yang, Stratton Charles, et al. (+3)
363 [GO] 2020―Jun―09 Patterns of IgG and IgM antibody response in COVID-19 patients Xuemei Liu, Jing Wang, Xiaolei Xu, Guojian Liao, Yaokai Chen, Chang-Hua Hu
364 [GO] 2020―Jun―04 Experimental Aerosol Survival of SARS-CoV-2 in Artificial Saliva and Tissue Culture Media at Medium and High Humidity Sophie J Smither, Lin S Eastaugh, James S Findlay, Mark S Lever
365 [GO] 2020―Jun―03 Targeting SARS-CoV-2 Receptors as a Means for Reducing Infectivity and Improving Antiviral and Immune Response: An Algorithm-based Method For Overcoming Resistance To Antiviral Agents Ram Gelman, Areej Bayatra, Asa Kessler, Asaf Schwartz, Yaron Ilan
366 [GO] 2020―Jun―01 Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression Liang Shen, Chunhua Wang, Jianzhong Zhao, Xiaoyong Tang, Ying Shen, Mingqing Lu, et al. (+7)
367 [GO] 2020―May―31 Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Huan Han, Qingfeng Ma, Cong Li, Rui Liu, Li Zhao, Wei Wang, et al. (+8)
368 [GO] 2020―May―30 Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV Nisreen M. A. Okba, Ivy Widjaja, Brenda van Dieren, Andrea Aebischer, Geert van Amerongen, Leon de Waal, et al. (+7)
369 [GO] 2020―May―27 Nurse Infected with Covid-19 from a Provisional Dengue Patient Wisit Prasitsirikul, Krit Pongpirul, Wannarat A. Pongpirul, Nayot Panitantum, Anuttra C. Ratnarathon, Thirawat Hemachudha
370 [GO] 2020―May―27 Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa Ishmael Festus Jaja, Madubuike Umunna Anyanwu, Chinwe-Juliana Iwu Jaja
371 [GO] 2020―May―27 COVID-19 pandemic - An African perspective Shabir Ahmad Lone, Aijaz Ahmad
372 [GO] 2020―May―27 Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2 Jonathan Hon-Kwan Chen, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Kwok-Hung Chan, Vincent Chi-Chung Cheng, Ivan Fan-Ngai Hung, et al. (+3)
373 [GO] 2020―May―25 Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets Xinjin Liu, Jiangpeng Feng, Qiuhan Zhang, Dong Guo, Lu Zhang, Tao Suo, et al. (+8)
374 [GO] 2020―May―22 ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens Tao Suo, Xinjin Liu, Jiangpeng Feng, Ming Guo, Wenjia Hu, Dong Guo, et al. (+17)
375 [GO] 2020―May―20 Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture Ya-Nan Zhang, Qiu-Yan Zhang, Xiao-Dan Li, Jin Xiong, Shu-Qi Xiao, Zhen Wang, et al. (+7)
376 [GO] 2020―May―18 Viral loads in throat and anal swabs in children infected with SARS-CoV-2 Chunhui Yuan, Hongmin Zhu, Yuan Yang, Xiaonan Cai, Feiyan Xiang, Huan Wu, et al. (+3)
377 [GO] 2020―May―14 Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity Jianbo Dong, Betty Huang, Zhejun Jia, Bo Wang, Sachith Gallolu Kankanamalage, Allison Titong, Yue Liu
378 [GO] 2020―May―08 Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2 Danielle E. Anderson, Chee Wah Tan, Wan Ni Chia, Barnaby E. Young, Martin Linster, JennyG. H. Low, et al. (+6)
379 [GO] 2020―May―07 Animal models for emerging coronavirus: progress and new insights Lunzhi Yuan, Qiyi Tang, Tong Cheng, Ningshao Xia
380 [GO] 2020―May―02 Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients Baoqing Sun, Ying Feng, Xiaoneng Mo, Peiyan Zheng, Qian Wang, Pingchao Li, et al. (+17)
381 [GO] 2020―Apr―28 Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Patient Jing Sun, Airu Zhu, Heying Li, Kui Zheng, Zhen Zhuang, Zhao Chen, et al. (+23)
382 [GO] 2020―Apr―27 Rheumotologitsts’ View on the Use of Hydroxychloroquine to Treat COVID-19 Xiaoxuan Sun, Yicheng Ni, Miaojia Zhang
383 [GO] 2020―Apr―27 Mathematic modeling of COVID-19 in the United States Yuanji Tang, Shixia Wang
384 [GO] 2020―Apr―23 Impact of population movement on the spread of 2019-nCoV in China Chi Zhang, Cai Chen, Wei Shen, Feng Tang, Hao Lei, Yu Xie, et al. (+14)
385 [GO] 2020―Apr―20 Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients Zhang Yongchen, Han Shen, Xinning Wang, Xudong Shi, Yang Li, Jiawei Yan, et al. (+2)
386 [GO] 2020―Apr―20 Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 Yun Hee Baek, Jihye Um, Khristine Joy C. Antigua, Ji-Hyun Park, Yeonjae Kim, Sol Oh, et al. (+11)
387 [GO] 2020―Apr―17 Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction Siu-Ying Lau, Pui Wang, Bobo Wing-Yee Mok, Anna Jinxia Zhang, Hin Chu, Andrew Chak-Yiu Lee, et al. (+9)
388 [GO] 2020―Apr―14 Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster Yan Xu, Meng Xiao, Xinchao Liu, Shengyong Xu, Tiekuan Du, Jun Xu, et al. (+6)
389 [GO] 2020―Apr―03 Diagnostic Value and Key Features of Computed Tomography in Coronavirus Disease 2019 Bingjie Li, Xin Li, Yaxuan Wang, Yikai Han, Yidi Wang, Chen Wang, et al. (+7)
390 [GO] 2020―Mar―31 Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients Yong Xiong, Yuan Liu, Liu Cao, Dehe Wang, Ming Guo, Ao Jiang, et al. (+13)
391 [GO] 2020―Mar―31 Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension Juan Meng, Guohui Xiao, Juanjuan Zhang, Xing He, Min Ou, Jing Bi, et al. (+7)
392 [GO] 2020―Mar―30 Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation Xi Zhang, Hin Chu, Lei Wen, Huiping Shuai, Dong Yang, Yixin Wang, et al. (+6)
393 [GO] 2020―Mar―25 The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19 Liang Su, Xiang Ma, Huafeng Yu, Zhaohua Zhang, Pengfei Bian, Yuling Han, et al. (+6)
394 [GO] 2020―Mar―25 Clinical observation and management of COVID-19 patients Taisheng Li, Hongzhou Lu, Wenhong Zhang
395 [GO] 2020―Mar―24 Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 Jianhui Nie, Qianqian Li, Jiajing Wu, Chenyan Zhao, Huan Hao, Huan Liu, et al. (+12)
396 [GO] 2020―Mar―20 Laboratory Diagnosis of Emerging Human Coronavirus Infections - The State of the Art Michael J. Loeffelholz, Yi-Wei Tang
397 [GO] 2020―Mar―20 Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia Ling Lin, Lianfeng Lu, Wei Cao, Taisheng Li
398 [GO] 2020―Mar―17 Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 Naveen Vankadari, Jacqueline A. Wilce
399 [GO] 2020―Mar―14 A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses Sin-Yee Fung, Kit-San Yuen, Zi-Wei Ye, Chi-Ping Chan, Dong-Yan Jin
400 [GO] 2020―Mar―14 Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) Taisheng Li
401 [GO] 2020―Mar―09 Timely development of vaccines against SARS-CoV-2 Shan Lu
402 [GO] 2020―Mar―09 Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination Pei Hao, Wu Zhong, Shiyang Song, Shiyong Fan, Xuan Li
403 [GO] 2020―Mar―03 Public’s early response to the novel coronavirus-infected pneumonia Siyi Zhan, Ying Ying Yang, Chuanxi Fu
404 [GO] 2020―Feb―27 Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity Weilie Chen, Yun Lan, Xiaozhen Yuan, Xilong Deng, Yueping Li, Xiaoli Cai, et al. (+15)
405 [GO] 2020―Feb―27 No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2 Shan-Lu Liu, Linda J. Saif, Susan R. Weiss, Lishan Su
406 [GO] 2020―Feb―24 Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent Jiyu Zhang, Yuru Han, Hongyan Shi, Jianfei Chen, Xin Zhang, Xiaobo Wang, et al. (+8)
407 [GO] 2020―Feb―17 Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody Xiaolong Tian, Cheng Li, Ailing Huang, Shuai Xia, Sicong Lu, Zhengli Shi, et al. (+5)
408 [GO] 2020―Feb―17 Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Wei Zhang, Rong-Hui Du, Bei Li, Xiao-Shuang Zheng, Xing-Lou Yang, Ben Hu, et al. (+5)
409 [GO] 2020―Feb―14 HIV-1 did not contribute to the 2019-nCoV genome Chuan Xiao, Xiaojun Li, Shuying Liu, Yongming Sang, Shou-Jiang Gao, Feng Gao
410 [GO] 2020―Feb―05 RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak Liangjun Chen, Weiyong Liu, Qi Zhang, Ke Xu, Guangming Ye, Weichen Wu, et al. (+11)
411 [GO] 2020―Feb―01 An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies Shibo Jiang, Lanying Du, Zhengli Shi
412 [GO] 2020―Jan―30 Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018 Yanqun Wang, Xin Li, Wenkuan Liu, Mian Gan, Lu Zhang, Jin Wang, et al. (+16)
413 [GO] 2020―Jan―28 Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan Jasper Fuk-Woo Chan, Kin-Hang Kok, Zheng Zhu, Hin Chu, Kelvin Kai-Wang To, Shuofeng Yuan, Kwok-Yung Yuen
414 [GO] 2020―Jan―22 Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Alexander Prokscha, Hassan Y. Naim, Marcel A. Müller, et al. (+3)
 [1] 

414 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec